Today: 20 May 2026
Dayforce stock price is 14 cents from $70 as take-private deal nears the finish line
4 February 2026
1 min read

Dayforce stock price is 14 cents from $70 as take-private deal nears the finish line

New York, Feb 3, 2026, 21:17 EST — Market closed

  • Dayforce shares ended Tuesday 1.36% higher at $69.86, just shy of the $70 cash offer by roughly 14 cents
  • A regulatory filing confirmed that all necessary approvals are secured, with the merger set to close within five business days, pending final conditions
  • Trading volume surged to 30.3 million shares, well beyond recent averages

Dayforce, Inc. shares climbed Tuesday as the company edged nearer to finalizing its pending sale. A recent filing revealed the merger is expected to close within five business days, pending necessary regulatory approvals.

That’s significant since the stock is currently hovering right around the $70-a-share cash offer, squeezing any potential gains and leaving minimal margin for mistakes for late buyers.

U.S. markets remain closed until Wednesday, leaving traders to focus on any new details about timing, paperwork, and the final steps needed to close the deal.

Dayforce shares climbed 1.36%, ending the session at $69.86, standing out amid a generally down day for stocks. The S&P 500 dropped 0.84%, while the Dow Jones Industrial Average edged down 0.34%, per MarketWatch data.

Volume in Dayforce surged as well, indicating that positioning remains in flux despite the stock hovering close to the offer price.

In its filing with the U.S. Securities and Exchange Commission, the company noted that the buyer — Dayforce Bidco, LLC — has secured the necessary regulatory approvals and aims to close the deal within “the next five (5) business days,” pending final closing conditions.

In August, the company agreed to be acquired by private equity firm Thoma Bravo in an all-cash transaction valued around $12.3 billion. Shareholders are set to receive $70 per share. The deal also involves a minority stake from a subsidiary of the Abu Dhabi Investment Authority, the company said at the time.

Shareholders gave the green light to the deal back in November. “This is an important milestone in our transaction,” CEO David Ossip remarked at the time. Dayforce Investors

Deal traders focus on the “deal spread” — the difference between the stock price and the offer. By Tuesday’s close, that spread had narrowed to roughly 0.2%, offering minimal room for delays in the timeline.

But the finish line isn’t certain yet. The company cautioned that closing depends on remaining conditions, and any hold-up, dispute, or legal battle could quickly widen the spread.

Dayforce operates in the competitive human capital management software space alongside rivals like Workday, ADP, and Paycom. Should the deal finalize, Dayforce will exit the public markets, removing a notable HCM player from the mix.

Next on the agenda: investors await the closing notice and any word on when the stock will cease trading on the New York Stock Exchange. If the five-business-day countdown starting Feb. 2 stays on track, all eyes will be on announcements near Feb. 9 — and whether anything disrupts the transition.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape
Previous Story

CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape

BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results
Next Story

BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results

Go toTop